21 CFR Part 606 - CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
- Subpart A - General Provisions (§ 606.3)
- Subpart B - Organization and Personnel (§ 606.20)
- Subpart C - Plant and Facilities (§ 606.40)
- Subpart D - Equipment (§§ 606.60 - 606.65)
- Subpart E [Reserved]
- Subpart F - Production and Process Controls (§§ 606.100 - 606.110)
- Subpart G - Additional Labeling Standards for Blood and Blood Components (§§ 606.120 - 606.122)
- Subpart H - Laboratory Controls (§§ 606.140 - 606.151)
- Subpart I - Records and Reports (§§ 606.160 - 606.171)
{'United States Code': [{'Title': '42', 'Section': '216', 'headtext': ' Regulations', 'cleanpath': '/uscode/text/42/216'}, {'Title': '42', 'Section': '262', 'headtext': ' Regulation of biological products', 'cleanpath': '/uscode/text/42/262'}, {'Title': '42', 'Section': '263', 'headtext': ' Preparation of biological products by Service', 'cleanpath': '/uscode/text/42/263'}, {'Title': '42', 'Section': '263a', 'headtext': ' Certification of laboratories', 'cleanpath': '/uscode/text/42/263a'}, {'Title': '42', 'Section': '264', 'headtext': ' Regulations to control communicable diseases', 'cleanpath': '/uscode/text/42/264'}, {'Title': '21', 'Section': '321', 'headtext': ' Definitions; generally', 'cleanpath': '/uscode/text/21/321'}, {'Title': '15', 'Section': '331', 'headtext': ' Omitted', 'cleanpath': '/uscode/text/15/331'}, {'Title': '21', 'Section': '331', 'headtext': ' Prohibited acts', 'cleanpath': '/uscode/text/21/331'}, {'Title': '21', 'Section': '351', 'headtext': ' Adulterated drugs and devices', 'cleanpath': '/uscode/text/21/351'}, {'Title': '21', 'Section': '352', 'headtext': ' Misbranded drugs and devices', 'cleanpath': '/uscode/text/21/352'}, {'Title': '21', 'Section': '355', 'headtext': ' New drugs', 'cleanpath': '/uscode/text/21/355'}, {'Title': '21', 'Section': '360', 'headtext': ' Registration of producers of drugs or devices', 'cleanpath': '/uscode/text/21/360'}, {'Title': '21', 'Section': '360j', 'headtext': ' General provisions respecting control of devices intended for human use', 'cleanpath': '/uscode/text/21/360j'}, {'Title': '21', 'Section': '360', 'headtext': ' Registration of producers of drugs or devices', 'cleanpath': '/uscode/text/21/360'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}, {'Title': '21', 'Section': '374', 'headtext': ' Inspection', 'cleanpath': '/uscode/text/21/374'}, {'Title': '5', 'Section': '553', 'headtext': ' Rule making', 'cleanpath': '/uscode/text/5/553'}, {'Title': '5', 'Section': '702', 'headtext': ' Right of review', 'cleanpath': '/uscode/text/5/702'}, {'Title': '5', 'Section': '703', 'headtext': ' Form and venue of proceeding', 'cleanpath': '/uscode/text/5/703'}, {'Title': '5', 'Section': '704', 'headtext': ' Actions reviewable', 'cleanpath': '/uscode/text/5/704'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}